Tumor characteristics (burden)-High Tumor Burden Posts on Medivizor
Navigation Menu

Tumor characteristics (burden)-High Tumor Burden Posts on Medivizor

Evaluating outcomes for patients with follicular lymphoma after rituximab maintenance therapy

Evaluating outcomes for patients with follicular lymphoma after rituximab maintenance therapy

Posted by on Aug 4, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at long-term outcomes for patients with follicular lymphoma after rituximab (Rituxan) maintenance therapy. This study concluded that rituximab maintenance helped improve long-term survival without disease progression compared to no treatment. Some background Follicular lymphoma (FL) is the second most common type of...

Read More

Evaluating lenalidomide plus R-CHOP in patients with high tumor burden follicular lymphoma

Evaluating lenalidomide plus R-CHOP in patients with high tumor burden follicular lymphoma

Posted by on Oct 5, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of lenalidomide (Revlimid) plus R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy in previously untreated patients with follicular lymphoma (FL) and a high tumor burden (a large number of cancer cells or tumors in the body). This study concluded that...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor